Update to 01/26/21 COVI-MSC™ Press Release: Fourth Patient Also Released From Hospital Following Third Infusion of Stem Cells

The primaryobjectiveis to evaluate the safety of intravenous infusion of allogeneic adiposeMSCcells in patients with COVID-19-induced ARDor ARDS.